{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200724",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "64092",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206966lbl.pdf",
              "date": "20200724",
              "type": "Label"
            },
            {
              "id": "64098",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/206966Orig1s000ltr.pdf",
              "date": "20200727",
              "type": "Letter"
            },
            {
              "id": "64371",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/206966Orig1s000TOC.html",
              "date": "20200821",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20220720",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "71617",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/206966Orig1s002ltr.pdf",
              "date": "20220721",
              "type": "Letter"
            },
            {
              "id": "71630",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206966Orig1s002lbl.pdf",
              "date": "20220725",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA206966",
      "sponsor_name": "LNHC",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "XEGLYZE",
          "active_ingredients": [
            {
              "name": "ABAMETAPIR",
              "strength": "0.74%"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "LOTION",
          "route": "TOPICAL",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}